Brochure | September 29, 2016

Rare Disease And Orphan Drug Research Brochure

Source: INC Research/inVentiv Health

While developing drugs to treat rare diseases is more viable from a business perspective than ever before, the clinical research and go-to-market planning process is still fraught with challenges. Regulations, protocols, logistics, and reporting are all different when patients are scarce, the stakes are high, and treatments are complex.